Federal Capture Intelligence

Top HHS in-vitro diagnostic substance manufacturing contractors (NAICS 325413)

Contract actions: October 1, 2021 – October 23, 2026 Updated October 24, 2026 Department of Health and Human Services agency guide NAICS 325413 · In-Vitro Diagnostic Substance Manufacturing
Latest 12 months
$12.4M
Net obligations · Up $2.4M vs. $9.9M preceding
Prime contractors
57
With positive obligations in the latest 12 months

Research the HHS federal contracting market for in-vitro diagnostic substance manufacturing under NAICS 325413. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, and potential recompete research leads.

Contract obligation trends for In-Vitro Diagnostic Substance Manufacturing at the Department of Health and Human Services

Federal records show $1.3B in net obligations across 2,083 awards in In-Vitro Diagnostic Substance Manufacturing at the Department of Health and Human Services from Oct 1, 2021 through Oct 23, 2026. This market accounts for 0.88% of $150.2B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations increased 24.7% from $9.9M to $12.4M. 16 prime contractors accounted for at least 80% of positive obligations in that latest period.

Fiscal-year activity

FY27 is year-to-date through Oct 23, 2026; earlier years show complete fiscal-year totals.

FY27 year-to-date: $299K versus −$79K through the same date in FY26 (Not comparable).
Net obligations · complete fiscal yearNet obligations · FY27 YTDContract actions
View fiscal-year data table
Fiscal yearNet obligationsContract actionsCoverage
FY2022$89.0M744Complete
FY2023$1.2B759Complete
FY2024$30.0M688Complete
FY2025$9.8M565Complete
FY2026$12.0M347Complete

Market at a glance

All reported prime contract awards
All-period net obligations
$1.3B
2,083 awards · 283 prime contractors
Latest 12-month movement
+24.7%
$12.4M vs. $9.9M
Leading eight prime share
62.8%
Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
Agency context
0.88% of $150.2B in agency-wide net obligations.
Set-aside share when reported
5.3% of 1,536 awards with reported set-aside status.
Set-aside reporting
82 set aside · 1,454 no set-aside · 547 not reported

What changed in the last 12 months?

Oct 24, 2025–Oct 23, 2026, compared with Oct 24, 2024–Oct 23, 2025.

Buyer demand

Reported obligations through PHOENIX AREA INDIAN HEALTH SVC increased
$2.4M→$4.0M+$1.6M
Latest-period activity spans 27 awards across 9 prime contractors.

Competitive shifts

BIOMERIEUX INC lost the most market share
8.8%→5.2%−3.6 percentage points
The contractor now ranks #3 by positive obligations, based on 17 reported actions.
CEPHEID gained the most market share
25.5%→28.9%+3.4 percentage points
The contractor now ranks #1 by positive obligations, based on 29 reported actions.

Market structure

Top-five contractor share decreased
58.9%→53.4%−5.5 percentage points
Contractors outside the top five now account for 46.6% of positive obligations.
How these findings are calculated

Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.

Federal contract obligations by funding office

See how positive obligations were attributed across funding offices in the 12 months ending Oct 23, 2026.

30.9% of positive obligations were attributed to PHOENIX AREA INDIAN HEALTH SVC. That represents $4.0M, up $1.6M from the preceding 12 months.

Latest 12-month share of positive obligations; the gray segment represents all other reported offices.

  1. PHOENIX AREA INDIAN HEALTH SVC30.9% · $4.0M · up $1.6M
  2. FDA OFFICE OF ACQ GRANT SVCS15.6% · $2.0M · down $668K
  3. NATIONAL INSTITUTES OF HEALTH - CC11.1% · $1.4M · down $343K
  4. NAVAJO AREA INDIAN HEALTH SVC9.5% · $1.2M · down $321K
  5. CDC OFFICE OF ACQUISITION SERVICES8.8% · $1.1M · up $653K
  6. All other reported offices24.2% of positive obligations
View reported office rankings, comparisons, and evidence

USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.

  1. Reported funding office

    PHOENIX AREA INDIAN HEALTH SVC

    #1Up 1 from #2

    Latest 12 months

    $4.0M

    30.9% of positive obligations

    Versus preceding 12 months

    +$1.6M

    9 active prime contractors · 27 awards

    View office comparison and evidence

    Reported obligations increased 65.1% from $2.4M to $4.0M. The office’s share of positive obligations moved from 17.3% to 30.9%, a change of +13.6 percentage points.

    The latest period contains 29 actions across 27 awards. The preceding period contained 15 active prime contractors and 60 awards.

  2. Reported funding office

    FDA OFFICE OF ACQ GRANT SVCS

    #2Down 1 from #1

    Latest 12 months

    $2.0M

    15.6% of positive obligations

    Versus preceding 12 months

    −$668K

    8 active prime contractors · 37 awards

    View office comparison and evidence

    Reported obligations decreased 25.0% from $2.7M to $2.0M. The office’s share of positive obligations moved from 19.1% to 15.6%, a change of −3.6 percentage points.

    The latest period contains 40 actions across 37 awards and 3 newly active prime contractors. The preceding period contained 5 active prime contractors and 31 awards.

    Leading award-level changes

  3. Reported funding office

    NATIONAL INSTITUTES OF HEALTH - CC

    #3Rank unchanged

    Latest 12 months

    $1.4M

    11.1% of positive obligations

    Versus preceding 12 months

    −$343K

    25 active prime contractors · 36 awards

    View office comparison and evidence

    Reported obligations decreased 19.4% from $1.8M to $1.4M. The office’s share of positive obligations moved from 12.7% to 11.1%, a change of −1.6 percentage points.

    The latest period contains 40 actions across 36 awards and 8 newly active prime contractors. The preceding period contained 37 active prime contractors and 66 awards.

  4. Reported funding office

    NAVAJO AREA INDIAN HEALTH SVC

    #4Rank unchanged

    Latest 12 months

    $1.2M

    9.5% of positive obligations

    Versus preceding 12 months

    −$321K

    25 active prime contractors · 61 awards

    View office comparison and evidence

    Reported obligations decreased 20.8% from $1.5M to $1.2M. The office’s share of positive obligations moved from 11.1% to 9.5%, a change of −1.6 percentage points.

    The latest period contains 80 actions across 61 awards and 2 newly active prime contractors. The preceding period contained 30 active prime contractors and 81 awards.

  5. Reported funding office

    CDC OFFICE OF ACQUISITION SERVICES

    #5Up 3 from #8

    Latest 12 months

    $1.1M

    8.8% of positive obligations

    Versus preceding 12 months

    +$653K

    21 active prime contractors · 31 awards

    View office comparison and evidence

    Reported obligations increased 135.1% from $483K to $1.1M. The office’s share of positive obligations moved from 3.5% to 8.8%, a change of +5.4 percentage points.

    The latest period contains 43 actions across 31 awards and 10 newly active prime contractors. The preceding period contained 19 active prime contractors and 25 awards.

  6. Reported funding office

    ALBUQUERQUE AREA INDIAN HEALTH SVC

    #6Down 1 from #5

    Latest 12 months

    $975K

    7.6% of positive obligations

    Versus preceding 12 months

    −$475K

    6 active prime contractors · 18 awards

    View office comparison and evidence

    Reported obligations decreased 32.7% from $1.4M to $975K. The office’s share of positive obligations moved from 10.4% to 7.6%, a change of −2.8 percentage points.

    The latest period contains 31 actions across 18 awards and 1 newly active prime contractor. The preceding period contained 6 active prime contractors and 37 awards.

  7. Reported funding office

    NIH NCI

    #7Up 2 from #9

    Latest 12 months

    $522K

    4.0% of positive obligations

    Versus preceding 12 months

    +$77K

    8 active prime contractors · 10 awards

    View office comparison and evidence

    Reported obligations increased 17.3% from $445K to $522K. The office’s share of positive obligations moved from 3.2% to 4.0%, a change of +0.9 percentage points.

    The latest period contains 10 actions across 10 awards and 6 newly active prime contractors. The preceding period contained 6 active prime contractors and 15 awards.

  8. Reported funding office

    NATIONAL INSTITUTES OF HEALTH OLAO

    #8Up 14 from #22

    Latest 12 months

    $366K

    2.8% of positive obligations

    Versus preceding 12 months

    +$322K

    10 active prime contractors · 13 awards

    View office comparison and evidence

    Reported obligations increased 746.1% from $43K to $366K. The office’s share of positive obligations moved from 0.31% to 2.8%, a change of +2.5 percentage points.

    The latest period contains 13 actions across 13 awards and 10 newly active prime contractors. The preceding period contained 3 active prime contractors and 3 awards.

  9. Reported funding office

    BARDA - ASPR / DAAPPO / BARDA DCMA

    #9Up 5 from #14

    Latest 12 months

    $335K

    2.6% of positive obligations

    Versus preceding 12 months

    +$111K

    2 active prime contractors · 2 awards

    View office comparison and evidence

    Reported obligations increased 49.8% from $223K to $335K. The office’s share of positive obligations moved from 1.6% to 2.6%, a change of +1.0 percentage points.

    The latest period contains 8 actions across 2 awards. The preceding period contained 4 active prime contractors and 4 awards.

  10. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NIA

    #10Down 4 from #6

    Latest 12 months

    $278K

    2.1% of positive obligations

    Versus preceding 12 months

    −$386K

    2 active prime contractors · 2 awards

    View office comparison and evidence

    Reported obligations decreased 58.1% from $663K to $278K. The office’s share of positive obligations moved from 4.8% to 2.1%, a change of −2.6 percentage points.

    The latest period contains 2 actions across 2 awards and 1 newly active prime contractor. The preceding period contained 11 active prime contractors and 14 awards.

  11. Reported funding office

    OFC ASST SEC FOR PREPARENESS RES

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    +$2.4M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations moved from $2.4M in net deobligations to $0 in net obligations. The office’s share of positive obligations moved from 0% to 0%, a change of 0.0 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 8 active prime contractors and 8 awards.

    Leading award-level changes

  12. Reported funding office

    ASPR/DAAPPO/ORM HQ

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    +$1.6M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations moved from $1.6M in net deobligations to $0 in net obligations. The office’s share of positive obligations moved from 0% to 0%, a change of 0.0 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 5 active prime contractors and 5 awards.

  13. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NIAID

    No positive-obligation rank

    Latest 12 months

    −$25K

    0% of positive obligations

    Versus preceding 12 months

    −$560K

    6 active prime contractors · 7 awards

    View office comparison and evidence

    Reported obligations moved from $535K in net obligations to $25K in net deobligations. The office’s share of positive obligations moved from 3.8% to 0%, a change of −3.8 percentage points.

    The latest period contains 7 actions across 7 awards and 3 newly active prime contractors. The preceding period contained 16 active prime contractors and 19 awards.

Contract types, competition, and procurement methods

From Oct 24, 2025 through Oct 23, 2026, 159 awards had positive obligations totaling $16.9M. Simplified Acquisition was the leading reported procedure, accounting for 42.3% of positive obligations. Awards with a reported parent IDV accounted for 60.5%.

Leading award type
39.5%
Purchase Order
Leading reported procedure
42.3%
Simplified Acquisition
Reported parent IDV
60.5%
of positive obligations had a reported parent IDV
Median reported offers
1
129 of 159 awards reported offers

Buying method changes

Compared with Oct 24, 2024–Oct 23, 2025. Based on 159 current awards and 278 preceding awards with positive net obligations.

Simplified Acquisition obligation share
42.3%
Down from 66.9% in the preceding period
Median positive award obligations
$49K
Up from $25K in the preceding period
How to read these changes

Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.

Same-NAICS comparison

Compared with the NAICS 325413 peer median, parent-IDV obligation share is 17.4 percentage points lower, reported full-and-open obligation share is 5.7 percentage points higher, delivery-order obligation share is 20.4 percentage points lower, and median positive award obligations are 1.8% higher.

MeasureThis marketPeer medianDifference
Parent-IDV obligation share60.5%77.8%-17.4 pts
Reported full-and-open obligation share15.7%10.0%+5.7 pts
Delivery-order obligation share23.1%43.5%-20.4 pts
Median positive award obligations$49K$48K+1.8%
Peer cohort and comparison limits

The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:

Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.

View buying-method details and data coverage

Award types

Reported valueAwardsPositive obligationsShare
Purchase Order(B)93$6.7M39.5%
BPA Call(A)28$6.3M37.3%
Delivery Order(C)38$3.9M23.1%

Reported parent-award types

Reported valueAwardsPositive obligationsShare
BPA(E)28$6.3M37.3%
IDC(B)25$2.5M14.6%
FSS(C)13$1.4M8.5%
Not reported93$6.7M39.5%

Single- or multiple-award parent structure

Reported valueAwardsPositive obligationsShare
Single Award(S)53$8.8M51.9%
Multiple Award(M)13$1.4M8.5%
Not reported93$6.7M39.5%

Solicitation procedures

Reported valueAwardsPositive obligationsShare
Simplified Acquisition(SP1)58$7.1M42.3%
Sp1(SIMPLIFIED ACQUISITION)41$3.7M22.0%
Subject to Multiple Award Fair Opportunity(MAFO)13$2.6M15.3%
Only One Source(SSS)29$1.8M10.5%
Sss(ONLY ONE SOURCE)12$1.1M6.4%
Mafo(SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY)5$513K3.0%
Other reported values1$68K0.40%

Extent competed

Reported valueAwardsPositive obligationsShare
Competed Under SAP(F)35$5.2M31.0%
Full and Open Competition(A)14$2.7M15.7%
Not Competed Under SAP(G)23$1.9M11.3%
F(COMPETED UNDER SAP)24$1.9M11.0%
G(NOT COMPETED UNDER SAP)17$1.9M11.0%
Not Competed(C)29$1.8M10.5%
Other reported values17$1.6M9.4%

Fair-opportunity and limited-source reporting

Reported valueAwardsPositive obligationsShare
Only One Source - Other(ONE)13$2.7M15.8%
Fair Opportunity Given(FAIR)5$439K2.6%
Not reported141$13.8M81.6%

Other-than-full-and-open reasons

Reported valueAwardsPositive obligationsShare
SAP Non-Competition (FAR 13)(SP2)35$3.3M19.6%
Only One Source-Other (FAR 6.302-1 Other)(ONE)39$2.6M15.6%
Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH)4$464K2.8%
Unique Source (FAR 6.302-1(B)(1))(UNQ)1$138K0.82%
Urgency (FAR 6.302-2)(URG)1$84K0.50%
Less Than or Equal to the Micro-Purchase Threshold(MPT)1$2K0.010%
Not reported78$10.3M60.8%

Contract pricing types

Reported valueAwardsPositive obligationsShare
Firm Fixed Price(J)101$11.6M68.6%
J(FIRM FIXED PRICE)58$5.3M31.4%

Product or Service Codes

Reported valueAwardsPositive obligationsShare
in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550)66$8.6M51.1%
Medical and Surgical Instruments, Equipment, and Supplies(6515)12$3.9M23.2%
Laboratory Equipment and Supplies(6640)39$2.7M15.9%
Drugs and Biologicals(6505)14$712K4.2%
Maint/Repair/Rebuild of Equipment- Instruments and Laboratory Equipment(J066)10$158K0.93%
Chemical and Pharmaceutical Products Manufacturing Machinery(3650)2$134K0.80%
Other reported values16$643K3.8%

Awarding subagencies

Reported valueAwardsPositive obligationsShare
Indian Health Service(7527)58$9.6M56.9%
National Institutes of Health(7529)56$3.7M21.7%
Food and Drug Administration(7524)25$2.0M12.0%
Centers for Disease Control and Prevention(7523)19$1.2M7.4%
Office of Assistant Secretary for Preparedness and Response(7505)1$335K2.0%

Awarding offices

Reported valueAwardsPositive obligationsShare
Phoenix Area Indian Health Svc(75H712)17$5.9M35.0%
National Institutes of Health Olao(75N980)43$2.2M13.3%
Navajo Area Indian Health Svc(75H710)27$2.1M12.3%
Fda Office of Acq Grant Svcs(75F401)25$2.0M12.0%
Albuquerque Area Indian Health Svc(75H707)9$1.4M8.6%
Cdc Office of Acquisition Services(75D301)19$1.2M7.4%
Other reported values19$1.9M11.4%

Reported parent IDVs

Reported valueAwardsPositive obligationsShare
75H71223A00001(7527)6$3.2M19.3%
75F40123D00001(7524)17$1.5M9.2%
75H71224A00007(7527)3$1.3M7.8%
36F79718D0395(3600)2$671K4.0%
75H71221A00002(7527)1$400K2.4%
75F40122D00010(7524)5$309K1.8%
75N98022A00032(7529)11$277K1.6%
V797D70110(3600)6$250K1.5%
Other reported values15$2.2M12.9%
Not reported93$6.7M39.5%

Offers, award size, and timing

Median reported offers
1 median
129 reported · 30 not reported
Positive award obligations
$49K median
$23K–$120K middle 50%
Reported performance period
364 days (~12 months) median
159 reported · 0 not reported

Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Oct 23, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.

Top federal contractors

Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.

Prime contractor concentration
16 of 57prime contractors account for at least 80% of positive obligations in the last 12 months
Largest prime contractor
28.9%of positive obligations in the last 12 months
Leading four prime contractors
50.0%of positive obligations in the last 12 months
Leading eight prime contractors
62.8%of positive obligations in the last 12 months

Based on $14.0M in positive obligations during the 12 months ending Oct 23, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Oct 24, 2024–Oct 23, 2025.

Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.

15 leading contractors
  1. #1

    Last 12mo obligations

    $4.0M

    28.9%

    Dollar movement

    −$736K

    vs. prior 12 months

    Last 12mo awards

    20 awards

    29 actions

    Historical and award details for CEPHEID
    Obligations: prior → latest
    $4.8M → $4.0M
    −15.4%
    Share: prior → latest
    25.5% → 28.9%
    +3.4 percentage points
    All-period obligations
    $19.0M
    1.4% of all-period positive obligations · 77 awards
    Recorded activity
    Since Dec 6, 2021
    through Sep 23, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside2028
    Not reported02
    Reported small business00
    All-period set-aside types

    None reported.

  2. #2

    Last 12mo obligations

    $1.7M

    11.9%

    Dollar movement

    −$653K

    vs. prior 12 months

    Last 12mo awards

    26 awards

    28 actions

    Historical and award details for ILLUMINA, INC.
    Obligations: prior → latest
    $2.3M → $1.7M
    −28.2%
    Share: prior → latest
    12.4% → 11.9%
    −0.5 percentage points
    All-period obligations
    $12.0M
    0.90% of all-period positive obligations · 129 awards
    Recorded activity
    Since Mar 25, 2022
    through Oct 22, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside45
    Not reported2221
    Reported small business00
    All-period set-aside types

    None reported.

  3. #3

    Last 12mo obligations

    $727K

    5.2%

    Dollar movement

    −$915K

    vs. prior 12 months

    Last 12mo awards

    16 awards

    17 actions

    Historical and award details for BIOMERIEUX INC
    Obligations: prior → latest
    $1.6M → $727K
    −55.7%
    Share: prior → latest
    8.8% → 5.2%
    −3.6 percentage points
    All-period obligations
    $4.4M
    0.33% of all-period positive obligations · 58 awards
    Recorded activity
    Since Oct 26, 2021
    through Sep 10, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside97
    Not reported78
    Reported small business00
    All-period set-aside types

    None reported.

  4. #4

    Last 12mo obligations

    $551K

    4.0%

    Dollar movement

    +$87K

    vs. prior 12 months

    Last 12mo awards

    14 awards

    17 actions

    Historical and award details for WERFEN USA LLC
    Obligations: prior → latest
    $464K → $551K
    +18.7%
    Share: prior → latest
    2.5% → 4.0%
    +1.5 percentage points
    All-period obligations
    $1.3M
    0.090% of all-period positive obligations · 33 awards
    Recorded activity
    Since May 15, 2023
    through Oct 20, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside43
    Not reported1015
    Reported small business00
    All-period set-aside types

    None reported.

  5. #5

    Last 12mo obligations

    $480K

    3.4%

    Dollar movement

    +$480K

    vs. prior 12 months

    Last 12mo awards

    6 awards

    8 actions

    Historical and award details for QUIDELORTHO SALES COMPANY, LLC
    Obligations: prior → latest
    $0 → $480K
    Not comparable
    Share: prior → latest
    0% → 3.4%
    +3.4 percentage points
    All-period obligations
    $480K
    0.040% of all-period positive obligations · 6 awards
    Recorded activity
    Since Nov 19, 2025
    through Oct 15, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside60
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  6. #6

    Last 12mo obligations

    $469K

    3.4%

    Dollar movement

    +$146K

    vs. prior 12 months

    Last 12mo awards

    10 awards

    14 actions

    Historical and award details for REMEL INC.
    Obligations: prior → latest
    $323K → $469K
    +45.1%
    Share: prior → latest
    1.7% → 3.4%
    +1.6 percentage points
    All-period obligations
    $2.0M
    0.15% of all-period positive obligations · 57 awards
    Recorded activity
    Since Nov 30, 2021
    through Sep 23, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside44
    Not reported65
    Reported small business01
    All-period set-aside types

    None reported.

  7. #7

    Last 12mo obligations

    $465K

    3.3%

    Dollar movement

    −$753K

    vs. prior 12 months

    Last 12mo awards

    17 awards

    17 actions

    Historical and award details for 10X GENOMICS, INC.
    Obligations: prior → latest
    $1.2M → $465K
    −61.8%
    Share: prior → latest
    6.5% → 3.3%
    −3.2 percentage points
    All-period obligations
    $6.8M
    0.51% of all-period positive obligations · 265 awards
    Recorded activity
    Since Dec 30, 2021
    through Sep 29, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside1754
    Not reported00
    Reported small business12
    All-period set-aside types
    • 22 · Total small business
  8. #8

    Last 12mo obligations

    $375K

    2.7%

    Dollar movement

    +$198K

    vs. prior 12 months

    Last 12mo awards

    4 awards

    6 actions

    Historical and award details for PROMEGA CORPORATION
    Obligations: prior → latest
    $177K → $375K
    +111.5%
    Share: prior → latest
    0.95% → 2.7%
    +1.7 percentage points
    All-period obligations
    $1.1M
    0.080% of all-period positive obligations · 17 awards
    Recorded activity
    Since Aug 3, 2022
    through Oct 22, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside44
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  9. #9

    Last 12mo obligations

    $357K

    2.5%

    Dollar movement

    +$357K

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for BEACON SCIENTIFIC INC
    Obligations: prior → latest
    $0 → $357K
    Not comparable
    Share: prior → latest
    0% → 2.5%
    +2.5 percentage points
    All-period obligations
    $357K
    0.030% of all-period positive obligations · 1 award
    Recorded activity
    Since Sep 2, 2026
    through Sep 2, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside10
    Not reported00
    Reported small business10
    All-period set-aside types

    None reported.

  10. #10

    Last 12mo obligations

    $343K

    2.5%

    Dollar movement

    −$375K

    vs. prior 12 months

    Last 12mo awards

    3 awards

    4 actions

    Historical and award details for ROCHE DIABETES CARE INC
    Obligations: prior → latest
    $718K → $343K
    −52.2%
    Share: prior → latest
    3.8% → 2.5%
    −1.4 percentage points
    All-period obligations
    $2.3M
    0.17% of all-period positive obligations · 22 awards
    Recorded activity
    Since Nov 29, 2021
    through Aug 28, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported36
    Reported small business00
    All-period set-aside types

    None reported.

  11. #11

    Last 12mo obligations

    $340K

    2.4%

    Dollar movement

    +$408K

    vs. prior 12 months

    Last 12mo awards

    17 awards

    19 actions

    Historical and award details for FISHER SCIENTIFIC COMPANY L.L.C.
    Obligations: prior → latest
    −$68K → $340K
    Not comparable
    Share: prior → latest
    0% → 2.4%
    +2.4 percentage points
    All-period obligations
    $3.3M
    0.25% of all-period positive obligations · 114 awards
    Recorded activity
    Since Nov 10, 2021
    through Oct 15, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside55
    Not reported1232
    Reported small business00
    All-period set-aside types

    None reported.

  12. #12

    Last 12mo obligations

    $336K

    2.4%

    Dollar movement

    +$306K

    vs. prior 12 months

    Last 12mo awards

    4 awards

    7 actions

    Historical and award details for NATIONAL ENVIRONMENTAL INC
    Obligations: prior → latest
    $29K → $336K
    +1040.2%
    Share: prior → latest
    0.16% → 2.4%
    +2.3 percentage points
    All-period obligations
    $559K
    0.040% of all-period positive obligations · 6 awards
    Recorded activity
    Since Sep 2, 2022
    through Sep 18, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside32
    Reported no set-aside10
    Not reported00
    Reported small business42
    All-period set-aside types
    • 3 · BUY INDIAN
    • 2 · Indian small business
  13. #13

    Last 12mo obligations

    $335K

    2.4%

    Dollar movement

    +$96K

    vs. prior 12 months

    Last 12mo awards

    1 award

    4 actions

    Historical and award details for ORASURE TECHNOLOGIES INC
    Obligations: prior → latest
    $239K → $335K
    +40.2%
    Share: prior → latest
    1.3% → 2.4%
    +1.1 percentage points
    All-period obligations
    $685K
    0.050% of all-period positive obligations · 6 awards
    Recorded activity
    Since Feb 28, 2022
    through Aug 17, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside12
    Not reported00
    Reported small business12
    All-period set-aside types
    • 1 · Total small business
  14. #14

    Last 12mo obligations

    $279K

    2.0%

    Dollar movement

    −$300K

    vs. prior 12 months

    Last 12mo awards

    13 awards

    13 actions

    Historical and award details for ROCHE DIAGNOSTICS CORPORATION
    Obligations: prior → latest
    $578K → $279K
    −51.8%
    Share: prior → latest
    3.1% → 2.0%
    −1.1 percentage points
    All-period obligations
    $94.0M
    7.0% of all-period positive obligations · 96 awards
    Recorded activity
    Since Oct 20, 2021
    through Aug 25, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside45
    Not reported913
    Reported small business00
    All-period set-aside types

    None reported.

  15. #15

    Last 12mo obligations

    $253K

    1.8%

    Dollar movement

    +$158K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    3 actions

    Historical and award details for OXFORD NANOPORE TECHNOLOGIES INC
    Obligations: prior → latest
    $95K → $253K
    +165.9%
    Share: prior → latest
    0.51% → 1.8%
    +1.3 percentage points
    All-period obligations
    $358K
    0.030% of all-period positive obligations · 5 awards
    Recorded activity
    Since Sep 8, 2023
    through Aug 28, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside23
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

Potential federal contract recompetes

Investigate potential recompetes surfaced by near-term end dates, award value, and recent contract changes.

ATLANTIC TRADING LLC

EOI::INITIAL RESCISSIONS OF HARMFUL EXECUTIVE ORDERS AND ACTIONS (JANUARY 20, 2025)::EOI NOTICE OF TERMINATION FOR CONVENIENCE

The reported potential end date is Oct 29, 2026. Current award value is 100.0% of reported potential value ($26.5M of $26.5M).

Performance period

99.2%

As of Oct 23, 2026Potential end Oct 29, 2026

Current award value as a share of potential value

100.0%

$26.5M current$26.5M potential
Supporting data

Reported performance starts Sep 5, 2024.

No later potential end date is reported; current and potential end dates are both Oct 29, 2026.

$26.5M is obligated against $26.5M in current reported award value (100.0%).

Reported potential end dates: Mar 4, 2026 → Apr 2, 2025 → Oct 29, 2026.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75A50424C00006

SIRO DIAGNOSTICS, INC.

ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM (READER) AND CUE SAMPLE WAND

The reported potential end date moved later 4 times in the latest 12 months.

Performance period

86.1%

As of Oct 23, 2026Potential end May 1, 2027

Current award value as a share of potential value

99.7%

$28.3M current$28.4M potential
Supporting data

Reported performance starts Aug 2, 2023.

No later potential end date is reported; current and potential end dates are both May 1, 2027.

$28.3M is obligated against $28.3M in current reported award value (100.0%).

Reported potential end dates: Dec 31, 2025 → Mar 31, 2026 → Jun 30, 2026 → Sep 30, 2026 → May 1, 2027.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75A50123C00036

QUIDEL CORP

THE PURPOSE OF THIS CONTRACT IS TO PROCURE OF OVER THE COUNTER (OTC) COVID-19 TESTS.

$97.5M is obligated on an award with a reported potential end date of April 7, 2028.

Performance period

72.7%

As of Oct 23, 2026Potential end Apr 7, 2028

Current award value as a share of potential value

100.0%

$97.5M current$97.5M potential
Supporting data

Reported performance starts Dec 7, 2022.

Current performance is reported through Apr 7, 2023.

$97.5M is obligated against $97.5M in current reported award value (100.0%).

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75A50223C00007

These are research leads, not confirmed recompetes. USAspending records through Oct 23, 2026; reported dates and values can change through later modifications.

Recent federal contract award activity

Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.

Deobligation

This action

−$943K

CEPHEID

ALBUQUERQUE AREA INDIAN HEALTH SVC

MODIFICATION P00012 TO DE-OBLIGATE EXCESS FUNDS.

Why it stands out

This award recorded a material contraction.

The action removed $943K. A deobligation does not by itself show lower requirement demand.

Award net obligations
$2.8M
Share of 12-month positive obligations
6.8%
Supporting data
Prime contractor
#1 · 28.9% share
+3.4 percentage points · $736K net decline; action exceeded it by $208K
Funding office
#6 · 7.6% attributed share
down 1 rank · −2.8 percentage points · $475K net decline; action exceeded it by $468K
Related:Largest share gain
PIID 75H70722P00094 · Mod P00012
Base award

This action

+$1.8M

CEPHEID

PHOENIX AREA INDIAN HEALTH SVC

NEW BPA CALL FOR CEPHEID SUPPLIES

Why it stands out

A new award added obligations despite weaker contractor activity.

The action represented 12.9% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $736K overall.

Award net obligations
$1.8M
Share of 12-month positive obligations
12.9%
Supporting data
Prime contractor
#1 · 28.9% share
$736K net decline despite this positive action
Funding office
#1 · 30.9% attributed share
up 1 rank · +13.6 percentage points · $1.6M net increase; action exceeded it by $233K
Related:Funding office gain
PIID 75H71226F28028
Base award

This action

+$1.2M

BIOMERIEUX INC

PHOENIX AREA INDIAN HEALTH SVC

BPA, BIOMERIEUX, BIOFIRE PANEL REAGENTS, PIMC LABORATORY DEPT, BPA CALL 26F28007

Why it stands out

A new award added obligations despite weaker contractor activity.

The action represented 8.7% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $915K overall.

Award net obligations
$1.2M
Share of 12-month positive obligations
8.7%
Supporting data
Prime contractor
#3 · 5.2% share
$915K net decline despite this positive action
PIID 75H71226F28007
Base award

This action

+$357K

BEACON SCIENTIFIC INC

CDC OFFICE OF ACQUISITION SERVICES

PROCUREMENT OF LATERAL FLOW CASSETTES FOR THE RAPID HIV NUCLEIC ACID DIAGNOSTIC TEST-EO 14893

Why it stands out

No activity for this contractor was reported in this market during the preceding 12 months.

The base action placed the contractor #9 in this market by positive obligations over the latest 12 months.

Award net obligations
$357K
Share of 12-month positive obligations
2.5%
Supporting data
Prime contractor
#9 · 2.5% share
Newly active in this market; no actions were reported in the preceding 12 months
Funding office
#5 · 8.8% attributed share
up 3 ranks · +5.4 percentage points · $653K net increase; action accounted for 54.6%
PIID 75D30126P21454
Deobligation

This action

−$345K

BIOFIRE DIAGNOSTICS LLC

NATIONAL INSTITUTES OF HEALTH - CC

TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.

Why it stands out

The award contracted while the contractor grew overall.

The action removed $345K while the contractor rose $1.2M.

Award net obligations
$1.3M
Share of 12-month positive obligations
2.5%
Supporting data
Prime contractor
0% share
$1.2M net increase despite this negative action
Funding office
#3 · 11.1% attributed share
−1.6 percentage points · $343K net decline; action exceeded it by $2K
PIID HHSN269201700022U · Mod P00007
Deobligation

This action

−$403K

ABBOTT RAPID DX NORTH AMERICA LLC

INDIAN HEALTH SERVICE

DEOB AND CLOSE: AGENCY WIDE IDIQ CONTRACT TO PROVIDE LABORATORY ANALYZERS, TESTING KITS/REAGENTS, ASSOCIATED PERIPHERALS, AND THE ASSOCIATED SUPPORT AND SERVICE AGREEMENTS IN ORDER TO EFFECTIVELY TEST FOR COVID-19 SPECIMENS, AND OTHER SAMPLES AND CUL

Why it stands out

This award recorded a material contraction.

The action removed $403K. A deobligation does not by itself show lower requirement demand.

Award net obligations
$55.1M
Share of 12-month positive obligations
2.9%
PIID 75H71122P00945 · Mod P00002
View recent award activity by date (10)
  1. PROMEGA CORPORATIONModification · PIID 75N90025P00207
    Action+$169K
    Award net obligations$464K
  2. ILLUMINA, INC.Deobligation · PIID 75F40123F19017
    Action>−$1
    Award net obligations$218K
  3. ALBA BIOSCIENCE, INC.Base award · PIID 75N98027P00013
    Action+$18K
    Award net obligations$18K
  4. WERFEN USA LLCBase award · PIID 75N98027P00015
    Action+$17K
    Award net obligations$17K
  5. FISHER SCIENTIFIC COMPANY L.L.C.Deobligation · PIID 75H70724F05037
    Action−$31K
    Award net obligations$20K
  6. QUIDELORTHO SALES COMPANY, LLCBase award · PIID 75N98027P00011
    Action+$126K
    Award net obligations$126K
  7. 10X GENOMICS, INC.Base award · PIID 75N98026F90033
    Action+$25K
    Award net obligations$25K
  8. STEMCELL TECHNOLOGIES INCBase award · PIID 75N98026P01928
    Action+$20K
    Award net obligations$20K
  9. PROMEGA CORPORATIONBase award · PIID 75N98026P01810
    Action+$48K
    Award net obligations$48K
  10. MESO SCALE DIAGNOSTICS LLCBase award · PIID 75N98026P01835
    Action+$65K
    Award net obligations$65K

HHS in-vitro diagnostic substance manufacturing market FAQs

Answers based on reported federal contract data.

Who are the top HHS in-vitro diagnostic substance manufacturing contractors?

In the 12 months through October 23, 2026, CEPHEID, ILLUMINA, INC., and BIOMERIEUX INC were the leading HHS in-vitro diagnostic substance manufacturing prime contractors by positive obligations.

  1. #1

    CEPHEID

    $4,036,038 in positive obligations

  2. #2

    ILLUMINA, INC.

    $1,659,928 in positive obligations

  3. #3

    BIOMERIEUX INC

    $727,290 in positive obligations

Rankings use reported USAspending award data.

Did HHS contract obligations increase in the in-vitro diagnostic substance manufacturing market?

Yes. Measured by net prime contract obligations, reported HHS activity in the in-vitro diagnostic substance manufacturing market increased 24.7% from $9,905,987 in the preceding 12 months to $12,355,146 in the 12 months through October 23, 2026.

Latest 12 months
$12,355,146
Net prime contract obligations
Preceding 12 months
$9,905,987
Net prime contract obligations
Change
+24.7%
Between matched 12-month periods

Reported contract actions, not outlays or a forecast.

What recent HHS contract award activity was reported in the in-vitro diagnostic substance manufacturing market?

Recent HHS contract award activity reported in the in-vitro diagnostic substance manufacturing market included actions for CEPHEID, BIOMERIEUX INC, and BEACON SCIENTIFIC INC during the 12 months through October 23, 2026.

Action obligations are transaction-level amounts, not current award-level obligations.

Which procurement methods were reported for HHS contracts under NAICS 325413?

From October 24, 2025 through October 23, 2026, HHS reported 159 positive-obligation awards for in-vitro diagnostic substance manufacturing under NAICS 325413. The leading award type was purchase order. The leading reported procedure was simplified acquisition.

Positive-obligation awards
159
Leading reported procedure
Simplified Acquisition
42.3% of positive obligations
Leading award type
Purchase Order
39.6% of positive obligations
Full and open
15.7%
of positive obligations
Reported parent IDV
60.5%
of positive obligations

Percentages use positive obligations as the denominator.

Which HHS in-vitro diagnostic substance manufacturing awards may warrant recompete research?

3 HHS in-vitro diagnostic substance manufacturing awards may warrant recompete research based on reported potential-end dates, including awards held by ATLANTIC TRADING LLC, SIRO DIAGNOSTICS, INC., and QUIDEL CORP.

Research leads, not confirmed recompetes. Dates may change through later modifications.

Apply this research to a live pursuit

Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.

See Sweetspot in action

Related market research

Complete market indexes:

Same NAICS at other agencies:

Nearby NAICS at this agency:

Markets sharing leading prime records:

Leading-prime vehicle memberships:

Company memberships do not establish award-channel use.

Reported obligations include contract actions from October 1, 2021 through October 23, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.

Review data methodology